these are averages so can’t be applied broadly, also a repurposed drug has a greater chance of success than a new drug. @coads yep not too late either I am thinking licensing deal after OLE extension readouts.
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-858
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
-0.010(5.88%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.5¢ | 16.0¢ | $188.5K | 1.155M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3223 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 58000 | 1 |
View Market Depth
| Last trade - 14.54pm 20/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |